Drug Information Analysis Service

Collins E . Maternal and fetal effects of acetaminophen and salicylates in pregnancy. Obstet Gynecol 1981; 58 (suppl 5): 57–62S.

Rudolph AM . Effects of aspirin and acetaminophen in pregnancy and in the newborn. Arch Intern Med 1981; 141: 358–63.

Richards ID . Congenital malformation and environmental influences in pregnancy. Br J Prev Soc Med 1969; 23: 218–25.

Saxen I . Association between oral clefts and drugs taken during pregnancy. Int J Epidemiol 1975; 4: 37–44.

Niederhoff H Zahradnik H . Analgesics during pregnancy. Am J Med 1983; 75: 117–20.

Nelson MM Forfar JO . Association between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1971; 1: 523–7.

Zieler S Rothman KJ . Congenital heart disease in relation to maternal use of bendectin and other drugs in early pregnancy. N Engl J Med 1985; 313: 347–52.

Turner G Collins E . Fetal effects of regular salicylate ingestion in pregnancy. Lancet 1975; 2: 338–9.

Karim SM Hillier K . Physiological roles and pharmacological actions of prostaglandins in relation to human reproduction. In: Karim SM , ed. Prostaglandins and reproduction. Baltimore: University Park Press, 1975: 23–76.

Lewis RB Schulman JD . Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labor. Lancet 1973; 2: 1159–61.

Collins E Turner G . Maternal effects of regular salicylate ingestion in pregnancy. Lancet 1975; 2: 335–8.

Pritchard JA Macdonald PC . Williams obstetrics. 16th ed. New York: Appleton-Century-Crofts, 1980: 487–93.

Rumack CM Guggenheim MA Rumack BH Peterson RG Johnson ML Braithwaite WR . Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol 1981; 58: 52–56S.

Wallenburg CS Dekker GA Makowitz JW Rofmans P . Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1–3.

Shapiro S Siskind V Monson RL Heinonen OP Kaufman DW Stone D . Perinatal mortality and birth weight in relation to aspirin taken during pregnancy. Lancet 1976; 1: 1375–6.

Reid JD . Effects of selected OTC medications on the unborn and newborn. Nurse Pract 1983; 8: 43–50.

Flower RJ Moncada S Vane JR . Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of gout. In: Gilman AG Goodman LS Rall TW Murad F . Goodman and Gilman's the pharmacological basis of therapeutics. New York: Macmillan, 1985: 674–715.

Curran JW Lawrence DN Jaffe H Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med 1984; 310: 69–75.

Feorino PM Jaffe HW Palmer E Transfusion-associated acquired immunodeficiency syndrome: evidence for persistent infection in blood donors. N Engl J Med 1985; 312: 1293–6.

Ammann AJ Cowan MJ Wara DW Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet 1983; 1: 956–8.

Feorino PM Kalyanaraman VS Haverkos HW Lymphadenopathy associated virus infection of a blood donor-recipient pair with acquired immunodeficiency syndrome. Science 1984; 225: 69–72.

Evatt BL Gomperts ED McDougal JS Ramsey RB . Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. N Engl J Med 1985; 312: 483–6.

Pneumocystis carinii pneumonia among persons with hemophilia. MMWR 1982; 31: 365–7.

Davis KC Horsburgh CR Hasiba U Schocket AL Kirkpatrick CH . Acquired immunodeficiency syndrome in a patient with hemophilia. Ann Intern Med 1983; 3: 284–6.

Elliott JL Hoppes WL Plat MS Thomas JG Patel IP Gansar A . The acquired immunodeficiency syndrome and Mycobacterium avium-intracellulare bacteremia in a patient with hemophilia. Ann Intern Med 1983; 98: 290–3.

Poon MC Landay A Prasthofer EF Stagno S . Acquired immunodeficiency syndrome with Pneumocystis carinii and Mycobacterium avium-intracellular infection in a previously healthy patient with classic hemophilia. Ann Intern Med 1983; 98: 287–90.

Provisional public health service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR 1985; 34: 1–5.

Sacks HS Rose DN Chalmers TC . Should the risk of acquired immunodeficiency syndrome deter hepatitis B vaccination? JAMA 1984; 252: 3375–7.

Stevens CE . No increased incidence of AIDS in recipients of hepatitis B vaccine. N Engl J Med 1983; 308: 1163–4.

Hepatitis B vaccine: evidence confirming lack of AIDS transmission. MMWR 1984; 33: 465–7.

Szmuness W Stevens CE Harley EJ Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303: 833–41.

Jacobson IM Dienstag JL Zachoval R Hanrahan BA Watkin SE Rubin RH . Lack of effect of hepatitis B vaccine on Tcell phenotypes. N Engl J Med 1984; 311: 1030–2.

Dienstag JL Werner BG McLane MF Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination. JAMA 1985; 254: 1064–6.

Papaevangelou G Kallinikos G Roumeliotou A Politou K . Risk of AIDS in recipients of hepatitis B vaccine. N Engl J Med 1985; 312: 376–7.

Recommendations for protection against viral hepatitis. MMWR 1985; 34: 315–324.

Chang T Heel RC . Ribaviran and inosiplex: a review of their present status in viral diseases. Drugs 1981; 22: 111–28.

Grieco MH Reddy MM Manvar D Ahuja KK Moriarty ML . In vivo immunomodulation by inosiplex in patients with AIDS and related complexes. Ann Intern Med 1984; 101: 206–7.

Haddad J . Isoprinosine treatment in 18 patients with SSPE: a controlled study. Ann Neurol 1980; 7: 185–8.

Glasky AJ Friebertshauser GE Halker JW Settineri RA Ginsberg T . The role of cell mediated immunity in the therapeutic action of isoprinosine on viral processes. Chemotherapy 1977; 6: 235–8.

Wybran J Famaey JP Gortz R Dab I Aleroot A Appleboom T . Inosiplex: a review of its immunological and clinical effects of disease. Adv Pharmacol Ther 1982; 6: 123–31.

Morin A Ballet J . A recent overview on in vitro and in vivo immunological activities of methisoprinol. Allergol Immunopathol (Madr) 1982; 10: 109–14.

Taylor WJ Durant RH Dyken PR . Treatment of subacute sclerosing panencephalitis: an overview. Drug Intell Clin Pharm 1984; 18: 375–81.

Silverberg R Brenner T Abramsky O . Inosiplex in the treatment of SSPE. Arch Neurol 1979; 36: 374–5.

Dyken PR Swift A Durant RH . Long-term follow-up of patients with SSPE treated with inosiplex. Ann Neurol 1982; 11: 359–64.

Vainiene M Czlonkowska A Korlak J . SSPE: influence of the clinical course and treatment with isoprinosine on non-specific cell mediated and humoral immunity. Acta Neurol Scand 1983; 67: 275–84.

Jones CE . Inosiplex therapy in SSPE. Lancet 1982; 1: 1034–7.

Huttenlocher PR Mattson RH . Isoprinosine in SSPE. Neurology 1979; 29: 763–71.

Durant RH Dyken PR Swift AV . The influence of inosiplex treatment on the neurological disability of subacute sclerosing panencephalitis. J Pediatr 1982; 101: 288–93.

Durant R . The effect of inosiplex on the survival of SSPE. Neurology 1983; 33: 1053–5.

Elfenbein GJ Saral R . Infectious disease during immune recovery after bone marrow transplantation. In: Allen JC , ed. Infection in the compromised host. Baltimore: Williams and Williams Co., 1981: 157–96.

Quinnan GV Masur H Rook AH Herpes virus infections in the acquired immune deficiency syndrome. JAMA 1984; 252: 72–7.

Allen JR . Epidemiology of the acquired immunodeficiency syndrome (AIDS) in the United States. Semin Oncol 1984; 11: 4–11.

Meyers JD McGuffin RW Neiman PE Singer JW Thomas ED . Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after bone marrow transplantation. J Infect Dis 1980; 141: 555–62.

Meyers JD McGuffin RW Bryson YJ Cantell K Thomas ED . Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 1982; 146: 80–4.

Wade JC Hintz M McGuffin RW Springmeyer SC Connor JD Meyers JD . Treatment of cytomegalovirus pneumonia with high dose acyclovir. Am J Med 1982; 73 (suppl lA): 249–56.

Shepp DH Newton BA Meyers JD . Intravenous lymphoblastoid interferon and acyclovir for treatment of cytomegaloviral pneumonia. J Infect Dis 1984; 150: 776–7.

Field AK Davies ME Dewitt C 9-(2-hydroxy-1-(hydroxymethyl) ethoxymethyl)guanine: a selective inhibitor of herpes group virus replication. Proc Natl Acad Sci USA 1983; 80: 4139–43.

Rasmussen L Chen PT Mullenar JG Merigan TC . Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl) guanine alone and in combination with human interferons. Antimicrob Agents Chemother 1984; 26: 441–5.

Tyms AS Davis JM Jeffries DJ . BWB759U, an analog of acyclovir, inhibits human cytomegalovirus in vitro. Lancet 1984; 2: 924–5.

Mar E Cheng Y Huang E . Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother 1983; 24: 518–21.

Felsenstein D D'Amico DJ Hirsch MS Treatment of cytomegalovirus retinitis with 9-(2-hydroxymethyl-4-(hydroxymethyl)ethoxymethyl)guanine. Ann Intern Med 1985; 103: 377–80.

Bach MC Bagwell SP Knapp NP Davis KM Hedstrom PS . 9-(1,3-dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 381–2.

Shepp DH Danliker PS De Mirande P Activity of 9-(2-hydroxy-1-(hydroxymethyl) ethoxymethyl) guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med 1985; 103: 368–73.

Pizzuto J Ambriz R . Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: multicentric trial of the Cooperative Latin American Group on Hemostasis and Thrombosis. Blood 1984; 64: 1179–83.

Ahn YS Harrington WJ Simon SR Mylvaganam R Pall LM So AG . Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 1983; 308: 1396–9.

Karpatkin S . Autoimmune thrombocytopenic purpura. Blood 1980; 56: 329–43.

Morris L Distenfeld A Amorosi E Karpatikin S . Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med 1982; 96: 714–7.

Harrington WJ Ahn YS So AG Danazol therapy of autoimmune thrombocytopenias (abstract). Blood 1982; 60: 186a.

Ahn YS Harrington WJ . Hepatosplenic peliosis after danazol and glucocorticoids for ITP (letter). N Engl J Med 1985; 312: 243.

Verlin M Laros RK Penner J . Treatment of refractory thrombocytopenic purpura with cyclophosphamide. Am J Hematol 1976; 1: 97–104.

Fehr J Hofmann V Kappeler U . Transient reversal of thrombocytopenia purpura in idiopathic thrombocytopenic purpura by high-dose intravenous gamma-globulin. N Engl J Med 1982; 306: 1254–8.

Wordell CJ Stubits EA Tietze KJ Gaska JA Cosgrove EM . Immune globulin in the treatment of autoimmune thrombocytopenic purpura. Clin Pharm 1985; 4: 206–13.

Ahn YS Byrnes JJ Harrington WJ The treatment of idiopathic thrombocytopenic purpura with vinblastine-loaded platelets. N Engl J Med 1978; 298: 1101–7.

Marder VJ Nusbacher J Anderson FW . One year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura. Transfusion 1981; 21: 291–8.

Fraser IS Burridge J . Danazol treatment and platelet function. Med J Aust 1980; 1: 313–4.

Chtmbira TH Cope E Anderson ABM Bolton FG . The effect of danazol on menorrhagia, coagulation mechanism, haematological indices and body weight. Br J Obstet Gynaecol 1979; 86: 46–50.

Agnello V Pariser K Gell J Gelfand J Tusksoy R Nuran . Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement. J Rheumatol 1983; 10: 682–7.

Cines DB Cassileth PA Kiss JE . Danazol therapy in myelodysplasia. Ann Intern Med 1985; 103: 58–60.

Walsh DM Nardi MA Karpatkin S . On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med 1984; 311: 635–9.

Fischl MA Ahn YS Klimas N Harrington WJ Fletcher MA . Use of danazol in autoimmune thrombocytopenia associated with the acquired immunodeficiency syndrome (abstract). Blood 1984; 64: 236a.

Metroka CE Moore A Sonnabend JA Cunningham-Rundler S . Risks with danazol in the acquired immunodeficiency syndrome (letter). Ann Intern Med 1984; 101: 564–5.